Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …

Leishmaniasis is a vector-borne infectious disease caused by different species of protozoa
from the Leishmania genus. Classically, the disease can be classified into two main clinical …

The transition from planktonic to sessile mode of bacterial growth facilitates the survival in
diverse environmental niches. Majority of bacterial infections involve biofilm formation …

The endemic strain of Leishmania donovani in Sri Lanka causes cutaneous leishmaniasis
(CL) rather than more common visceral form. We have visualized biofilms and profiled the …

Background Treatment of cutaneous leishmaniasis (CL) remains challenging since the
drugs currently used are quite toxic, thus contributing to lethality unrelated to the disease …

Ethnopharmacological relevance Leishmaniasis are widely distributed among tropical and
subtropical countries, and remains a crucial health issue in Amazonia. Indigenous groups …

Bacterial infections in wounds significantly impair the healing process. The use of natural
antibacterial products over synthetic antibiotics has emerged as a new trend to address …

Cutaneous Leishmaniasis (CL) is a tropical disease characterized by cutaneous ulcers,
sometimes with satellite lesions and nodular lymphangitis. Leishmania parasites …

Purpose Leishmaniasis is a disease caused by different Leishmania spp., which are
transmitted to humans by a bite of infected female sand flies. Cutaneous leishmaniasis (CL …

Cutaneous leishmaniasis (CL) lesions are chronic and result in disfiguring scars. The
microbiological aspects of these wounds have not been systematically investigated. We …